Watchlist Price Alert

Artelo Biosciences Inc. (ARTL)

NASDAQ: ARTL · Real-Time Price · USD

0.99

-0.06 (-5.71%)

At close: May 06, 2025, 10:41 AM

Artelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016
Net Income	-10.08M	-7.44M	-4.65M	-2.17M	-2.34M	-234.89K	-29.69K
Depreciation & Amortization	n/a	n/a	500.00	510.00	282.00	600.00	n/a
Stock-Based Compensation	2.46M	1.53M	377.77K	425.11K	290K	3.33K	n/a
Other Working Capital	-195K	-239K	-169.26K	40.39K	-57.51K	-1.5K	n/a
Other Non-Cash Items	-211K	7K	-29.5K	100K	n/a	600.00	n/a
Deferred Income Tax	n/a	n/a	n/a	-1.01M	n/a	-600	n/a
Change in Working Capital	-172K	-242K	-41.28K	-140.02K	443.19K	14.14K	11.2K
Operating Cash Flow	-8.01M	-6.14M	-4.35M	-2.79M	-1.61M	-216.82K	-18.49K
Capital Expenditures	n/a	n/a	n/a	-1.5M	-845	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-13.22M	-3.44M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	16.18M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	2.96M	-3.44M	n/a	-1.5M	-845	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-108	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	6.01M	3.15K	1.05K	1.84K	42.67K	5.05K
Financial Cash Flow	n/a	14.11M	1.98M	8.38M	1.39M	785.35K	5.05K
Net Cash Flow	-5.27M	4.49M	-2.28M	4.09M	-235.35K	569.18K	-13.44K
Free Cash Flow	-8.01M	-6.14M	-4.35M	-4.29M	-1.61M	-216.82K	-18.49K